Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Monitoring Strategies in Individuals With Prior Hepatitis B Virus Exposure Undergoing Anti-CD20 Antibody Containing Chemotherapy: A Prospective Observational Study

NCT03155984 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT03155984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Monitoring Strategies in Individuals With Prior Hepatitis B Virus Exposure Undergoing Anti-CD20 Antibody Containing Chemotherapy: A Prospective Observational Study
Lead sponsor
The University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
October 1, 2013
Completion date
December 1, 2017
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, immune suppression, liver dysfunction